Parand Darou Pharmaceutical Co. — complete B2B supplier profile on TraidB
About Parand Darou Pharmaceutical Co.
As a knowledge-based company, Parand Darou pharmaceutical company started its activity in 2006 with the production of Narcotic APIs. Parand Darou Company is the second company in the private sector that received the license to produce narcotic products from the Food and Drug Organization of Iran. Extracting the Opioid raw materials, manufactured effective medicinal substances such as Codeine Phosphate, Noscapine, Thebaine, Papaverine and Oxycodone, in addition to meet the needs of domestic customers, it has exported its products to the world markets. In 2019, the company established a syrup line and received a GMP certificate and launched the production cycle of narcotic FDF as well. In July 2022, Kimyagaran Group (public stock) purchased the management shares of Parand Darou Pharmaceutical Company and aims to create a turning point in the growth, development and excellence of the company by cooperating with the expert and experienced management team.
Vision
Health Beyond Boundaries
PD
Parand Darou Pharmaceutical Co.
Manufacturer
See the full company profile
Sign in to view Parand Darou Pharmaceutical Co.'s products, services, certificates and direct contact details.
Products
Contact details
Certificates
Services
About Us
As a knowledge-based company, Parand Darou pharmaceutical company started its activity in 2006 with the production of Narcotic APIs. Parand Darou Company is the second company in the private sector that received the license to produce narcotic products from the Food and Drug Organization of Iran. Extracting the Opioid raw materials, manufactured effective medicinal substances such as Codeine Phosphate, Noscapine, Thebaine, Papaverine and Oxycodone, in addition to meet the needs of domestic customers, it has exported its products to the world markets. In 2019, the company established a syrup line and received a GMP certificate and launched the production cycle of narcotic FDF as well. In July 2022, Kimyagaran Group (public stock) purchased the management shares of Parand Darou Pharmaceutical Company and aims to create a turning point in the growth, development and excellence of the company by cooperating with the expert and experienced management team.
فعلاً توضیحی برای این شرکت ثبت نشده است.
Our Vision
Health Beyond Boundaries
فعلاً چشماندازی برای این شرکت ثبت نشده است.
Login to View Processes
This information is available only to registered users.
Login
